Spyre Therapeutics Inc
SYRELatest QuantConomy context for SYRE: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Spyre Therapeutics Inc
QuantConomy has a structured record for SYRE. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- SYRE
- Name
- Spyre Therapeutics Inc
- Coverage
- 3 market/data records
- Sources
- alpaca alphavantage fmp sec nasdaq
Recent signals for SYRE
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| volume volume spike | neutral | 41 | Jul 10, 05:37 PM | SYRE volume spike: 386% of expected volume for Friday 17:00 UTC, price flat 0.09% (strength 41) |
| volume volume spike | neutral | 40 | Jul 10, 04:35 PM | SYRE volume spike: 345% of expected volume for Friday 16:00 UTC, price flat 0.06% (strength 40) |
| price downtrend | slightly bearish | 27 | Jul 10, 03:37 PM | SYRE downtrend (drop): price -1.37% (strength 27, current 97.42) |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
PROPOSED_SALE signals are experimental: historical Form 144 coverage is still being backfilled, so results may be sparse or empty.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| SYRE | NASDAQ | alpaca | Spyre Therapeutics, Inc. Common Stock |
| SYRE | NASDAQ | alphavantage | Spyre Therapeutics Inc |
| SYRE | NASDAQ | fmp | Spyre Therapeutics, Inc. |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Sloan Sheldon | Chief Medical Officer | exercise | 8,334 | $27.46 | $228,852 | 4 on EDGAR |
| Jul 1, 2026 | Burrows Scott L | Chief Financial Officer | exercise | 7,500 | $14.50 | $108,750 | 4 on EDGAR |
| Jul 1, 2026 | Turtle Cameron | Chief Executive Officer | sale | 10,176 | $87.44 | $889,789 | 4 on EDGAR |
| Jun 25, 2026 | Burrows Scott L | Chief Financial Officer | exercise | 15,000 | $14.50 | $217,500 | 4 on EDGAR |
| Jun 23, 2026 | Fairmount Funds Management LLC | Insider | other | 666,680 | — | — | 4 on EDGAR |
| Jun 22, 2026 | HENDERSON MICHAEL THOMAS | Insider | sale | 20,000 | $100.00 | $2,000,000 | 4 on EDGAR |
| Jun 3, 2026 | Sloan Sheldon | Chief Medical Officer | exercise | 8,333 | $27.46 | $228,824 | 4 on EDGAR |
| Jun 1, 2026 | Burrows Scott L | Chief Financial Officer | exercise | 7,500 | $14.50 | $108,750 | 4 on EDGAR |
| Jun 1, 2026 | Turtle Cameron | Chief Executive Officer | sale | 3,557 | $69.40 | $246,856 | 4 on EDGAR |
| May 27, 2026 | Milligan Sandra | Insider | grant | 8,026 | — | — | 4 on EDGAR |
| May 27, 2026 | HENDERSON MICHAEL THOMAS | Insider | grant | 8,026 | — | — | 4 on EDGAR |
| May 27, 2026 | Fairmount Funds Management LLC | Insider | grant | 8,026 | — | — | 4 on EDGAR |
| May 27, 2026 | Albers Jeffrey W. | Insider | grant | 8,026 | — | — | 4 on EDGAR |
| May 27, 2026 | Stelzer Laurie | Insider | grant | 8,026 | — | — | 4 on EDGAR |
| May 27, 2026 | McKenna Mark C. | Insider | grant | 8,026 | — | — | 4 on EDGAR |
| May 8, 2026 | HENDERSON MICHAEL THOMAS | Insider | sale | 2,404 | $72.57 | $174,458 | 4 on EDGAR |
| May 1, 2026 | Sloan Sheldon | Chief Medical Officer | exercise | 78,333 | $27.46 | $2,151,024 | 4 on EDGAR |
| May 1, 2026 | Turtle Cameron | Chief Executive Officer | sale | 5,300 | $69.54 | $368,562 | 4 on EDGAR |
| May 1, 2026 | Burrows Scott L | Chief Financial Officer | exercise | 12,500 | $14.50 | $181,250 | 4 on EDGAR |
| Apr 1, 2026 | Sloan Sheldon | Chief Medical Officer | exercise | 7,958 | $21.66 | $172,370 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query SYRE context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access